Abstract:We thank Drs Jiang and Mao for their insightful comments regarding our recent article.1Xu X Chen Q Liang S Lv H Qiu Z Comparison of Gastroesophageal Reflux Disease Questionnaire and multichannel intraluminal impedance pH monitoring in identifying patients with chronic cough responsive to antireflux therapy.Chest. 2014; 145: 1264-1270Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar The goal of the study is to select the appropriate patients for empirical antireflux trial and to improve therapeutic gains. Actually, the patients were lifetime nonsmokers or ex-smokers for at least 2 years. The patients received an initial laboratory workup that included all the examinations Drs Jiang and Mao mentioned except for those patients with the obvious reflux-related symptoms, who accepted the evaluation of gastroesophageal reflux-induced chronic cough (GERC). Therefore, no other common causes of chronic cough were identified or were the explanation for their cough in the patients with potential GERC when recruited. Because of the limit of words in the text, we did not describe the relevant laboratory investigations in detail. GERC can only be confirmed by the favorable response to antireflux therapy, irrespective of laboratory findings.2Irwin RS Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines.Chest. 2006; 129: 80S-94SAbstract Full Text Full Text PDF PubMed Scopus (240) Google Scholar Acid suppressive therapy is the mainstay for the management of GERC,2Irwin RS Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines.Chest. 2006; 129: 80S-94SAbstract Full Text Full Text PDF PubMed Scopus (240) Google Scholar whereas body weight loss and lifestyle modification are conditionally recommended in some patients for long-term management of the disorder.3Katz PO Gerson LB Vela MF Guidelines for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2013; 108: 308-328Crossref PubMed Scopus (1082) Google Scholar Although currently there is controversy, the use of acid suppressive therapy for GERC is favorably concluded in a recent systematic review4Kahrilas PJ Howden CW Hughes N Molloy-Bland M Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.Chest. 2013; 143: 605-612Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar and recommended in a recent guideline for the management of gastroesophageal reflux disease.3Katz PO Gerson LB Vela MF Guidelines for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2013; 108: 308-328Crossref PubMed Scopus (1082) Google Scholar This is supported by our data that standard acid suppression resolved the cough in most patients with GERC, and only one-fourth of patients needed an intensified antireflux trial. We agree with Drs Jiang and Mao that further study is necessary to definitely define the benefit of acid suppression in GERC. In our study, 33 patients with GERC (32.4%) had other concomitant causes of chronic cough. Among eight responders to baclofen as an add-on therapy, one patient had concomitant cough variant asthma plus upper airway cough syndrome, one patient had concomitant eosinophilic bronchitis, and the remaining six patients had no other causes other than GERC to be identified. We agree with Drs Jiang and Mao that cough induced by any causes may respond to baclofen because of its nonspecific antitussive activity. However, the patients had objective laboratory evidence of abnormal reflux and only partially responded to previous therapies specific to the concomitant causes. Therefore, we believe the improvement in cough, at least partially, can be attributed to GERC, since baclofen has an established antireflux effect through the inhibition of transient lower esophageal sphincter relaxations.3Katz PO Gerson LB Vela MF Guidelines for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2013; 108: 308-328Crossref PubMed Scopus (1082) Google Scholar, 5Xu XH Yang ZM Chen Q et al.Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.World J Gastroenterol. 2013; 19: 4386-4392Crossref PubMed Scopus (34) Google Scholar There Are Still Problems in Establishing a Diagnosis of Gastroesophageal Reflux-Related Chronic CoughCHESTVol. 146Issue 1PreviewA recent study of 281 patients with extraesophageal syndromes of gastroesophageal reflux disease, of whom 50% had a cough, estimated that 52% of the overall US national annual economic burden of extraesophageal syndromes was attributable to proton pump inhibitor therapy.1 It is becoming increasingly important to identify patient populations likely to be responsive, avoiding unnecessary or inappropriate treatment. Xu et al2 should be congratulated on their study recently published in CHEST (June 2014) applying the Gastroesophageal Reflux Disease Questionnaire to predict patients with gastroesophageal reflux-induced chronic cough (GERC) who may be responsive to antireflux therapy. Full-Text PDF

Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease

Research advance on interstitial lung disease associated cough

Managing Cough in Idiopathic Pulmonary Fibrosis

What causes cough in pulmonary fibrosis, and how should we treat it?

Determinants of cough-related quality of life in interstitial lung diseases

Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT

Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study

New Insights into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.

The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis

Detection of levels of serum interleukin-17, interleukin-33 and concentration of fractional exhaled nitric oxide in patients with chronic cough and its clinical significance

Productive cough associated with patient-reported outcomes and computed tomography analysis results in idiopathic pulmonary fibrosis: a single centre cross-sectional study

[Changes in the Spectrum and Frequency of Causes for Chronic Cough: a Retrospective Analysis].

Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study

A Prospective Study on the Causes of Chronic Cough

Mechanisms and management of cough in interstitial lung disease

There Are Still Problems in Establishing a Diagnosis of Gastroesophageal Reflux-Related Chronic Cough: Response

[Changes and Implications of Esophageal Function in Patients with Chronic Cough Induced by Gastroesophageal Reflux].

The Value of Fractional Exhaled Nitric Oxide and Forced Mid-Expiratory Flow As Predictive Markers of Bronchial Hyperresponsiveness in Adults with Chronic Cough.

Cough in chronic lung disease: a state of the art review

Burden of refractory and unexplained chronic cough on patients' lives: a cohort study

Retrospective Study on Prognostic Factors of Idiopathic Pulmonary Fibrosis